168 related articles for article (PubMed ID: 19406636)
1. NO donors. Part 18: Bioactive metabolites of GTN and PETN--synthesis and vasorelaxant properties.
Lange K; Koenig A; Roegler C; Seeling A; Lehmann J
Bioorg Med Chem Lett; 2009 Jun; 19(11):3141-4. PubMed ID: 19406636
[TBL] [Abstract][Full Text] [Related]
2. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J
J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
[TBL] [Abstract][Full Text] [Related]
3. Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.
Wenzel P; Hink U; Oelze M; Seeling A; Isse T; Bruns K; Steinhoff L; Brandt M; Kleschyov AL; Schulz E; Lange K; Weiner H; Lehmann J; Lackner KJ; Kawamoto T; Münzel T; Daiber A
Br J Pharmacol; 2007 Feb; 150(4):526-33. PubMed ID: 17220910
[TBL] [Abstract][Full Text] [Related]
4. Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C.
Dikalov S; Fink B; Skatchkov M; Bassenge E
Free Radic Biol Med; 1999 Jul; 27(1-2):170-6. PubMed ID: 10443933
[TBL] [Abstract][Full Text] [Related]
5. Glyceryl trinitrate-induced vasodilation is inhibited by ultraviolet irradiation despite enhanced nitric oxide generation: evidence for formation of a nitric oxide conjugate.
Hussain AS; Crispino NH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Pharmacol Exp Ther; 1999 May; 289(2):895-900. PubMed ID: 10215668
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
Daiber A; Oelze M; Coldewey M; Bachschmid M; Wenzel P; Sydow K; Wendt M; Kleschyov AL; Stalleicken D; Ullrich V; Mülsch A; Münzel T
Mol Pharmacol; 2004 Dec; 66(6):1372-82. PubMed ID: 15331769
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate: a novel mechanism to explain preferential venodilation of organic nitrates.
Kojda G; Patzner M; Hacker A; Noack E
Mol Pharmacol; 1998 Mar; 53(3):547-54. PubMed ID: 9495823
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.
Hashimoto S; Kobayashi A
Clin Pharmacokinet; 2003; 42(3):205-21. PubMed ID: 12603173
[TBL] [Abstract][Full Text] [Related]
9. A liquid chromatographic-mass spectrometric procedure for analysis of pentaerythrityl tetranitrate metabolites - Development, validation and application to ovine serum and human plasma samples.
Städtler M; Wissenbach D; Wissenbach DK; Franke L; Pastuschek J; Schleussner E; Allison B; Peters FT; Groten T
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1234():124028. PubMed ID: 38330519
[TBL] [Abstract][Full Text] [Related]
10. Impaired vasodilator response to organic nitrates in isolated basilar arteries.
Martens D; Kojda G
Br J Pharmacol; 2001 Jan; 132(1):30-6. PubMed ID: 11156558
[TBL] [Abstract][Full Text] [Related]
11. NO donors. Part 16: investigations on structure-activity relationships of organic mononitrates reveal 2-nitrooxyethylammoniumnitrate as a high potent vasodilator.
Koenig A; Roegler C; Lange K; Daiber A; Glusa E; Lehmann J
Bioorg Med Chem Lett; 2007 Nov; 17(21):5881-5. PubMed ID: 17855086
[TBL] [Abstract][Full Text] [Related]
12. Thiol agents separate nitric oxide formation from vasodilation induced by glyceryl trinitrate.
Kearney MF; Brien JF; Marks GS; Lei H; Nakatsu K
Drug Metab Dispos; 1998 Jun; 26(6):547-51. PubMed ID: 9616190
[TBL] [Abstract][Full Text] [Related]
13. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance.
Dikalov S; Fink B; Skatchkov M; Stalleicken D; Bassenge E
J Pharmacol Exp Ther; 1998 Aug; 286(2):938-44. PubMed ID: 9694953
[TBL] [Abstract][Full Text] [Related]
14. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
Salvemini D; Pistelli A; Anggard E
Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
[TBL] [Abstract][Full Text] [Related]
15. Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction.
Münzel T; Steven S; Daiber A
Vascul Pharmacol; 2014 Dec; 63(3):105-13. PubMed ID: 25446162
[TBL] [Abstract][Full Text] [Related]
16. [Therapy with NO donors-antiatherogenic and antioxidant actions].
Grosser N; Schröder H
Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
[TBL] [Abstract][Full Text] [Related]
17. NO donors, part 8 [1]: synthesis and vasodilating activities of substituted benzylnitrates compared to cyclohexylmethylnitrate and GTN.
Wessler C; Homann A; Fricke U; Lehmann J
Eur J Med Chem; 2003 Jun; 38(6):581-6. PubMed ID: 12832129
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and vasorelaxant properties of hybrid molecules out of NO-donors and the beta-receptor blocking drug propranolol.
Decker M; König A; Glusa E; Lehmann J
Bioorg Med Chem Lett; 2004 Oct; 14(19):4995-7. PubMed ID: 15341967
[TBL] [Abstract][Full Text] [Related]
19. NO-donors, part X [1] : investigations on the stability of pentaerythrityl tetranitrate (PETN) by HPLC-chemoluminescence-N-detection (CLND) versus UV-detection in HPLC.
Seeling A; Lehmann J
J Pharm Biomed Anal; 2006 Mar; 40(5):1131-6. PubMed ID: 16257501
[TBL] [Abstract][Full Text] [Related]
20. Bioactivation of pentaerythrityl tetranitrate by mitochondrial aldehyde dehydrogenase.
Griesberger M; Kollau A; Wölkart G; Wenzl MV; Beretta M; Russwurm M; Koesling D; Schmidt K; Gorren AC; Mayer B
Mol Pharmacol; 2011 Mar; 79(3):541-8. PubMed ID: 21156756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
